ID17794A - Bentuk dosis gelatin lunak multi fasa - Google Patents

Bentuk dosis gelatin lunak multi fasa

Info

Publication number
ID17794A
ID17794A IDP972263A ID972263A ID17794A ID 17794 A ID17794 A ID 17794A ID P972263 A IDP972263 A ID P972263A ID 972263 A ID972263 A ID 972263A ID 17794 A ID17794 A ID 17794A
Authority
ID
Indonesia
Prior art keywords
dosage
multi phase
gelatin soft
soft multi
gelatin
Prior art date
Application number
IDP972263A
Other languages
English (en)
Indonesian (id)
Inventor
Michael R Hoy
Original Assignee
Mcneil Ppc Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Mcneil Ppc Inc filed Critical Mcneil Ppc Inc
Publication of ID17794A publication Critical patent/ID17794A/id

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4808—Preparations in capsules, e.g. of gelatin, of chocolate characterised by the form of the capsule or the structure of the filling; Capsules containing small tablets; Capsules with outer layer for immediate drug release
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A61K31/451—Non condensed piperidines, e.g. piperocaine having a carbocyclic group directly attached to the heterocyclic ring, e.g. glutethimide, meperidine, loperamide, phencyclidine, piminodine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/74—Synthetic polymeric materials
    • A61K31/80—Polymers containing hetero atoms not provided for in groups A61K31/755 - A61K31/795
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4816—Wall or shell material
    • A61K9/4825—Proteins, e.g. gelatin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4858—Organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4866—Organic macromolecular compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/12—Antidiarrhoeals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
IDP972263A 1996-06-28 1997-06-30 Bentuk dosis gelatin lunak multi fasa ID17794A (id)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US08/671,979 US6024980A (en) 1996-06-28 1996-06-28 Multiphase soft gelatin dosage form

Publications (1)

Publication Number Publication Date
ID17794A true ID17794A (id) 1998-01-29

Family

ID=24696660

Family Applications (1)

Application Number Title Priority Date Filing Date
IDP972263A ID17794A (id) 1996-06-28 1997-06-30 Bentuk dosis gelatin lunak multi fasa

Country Status (24)

Country Link
US (1) US6024980A (cs)
EP (1) EP0815855B1 (cs)
JP (1) JPH10182437A (cs)
KR (1) KR980000438A (cs)
CN (1) CN1172642A (cs)
AR (1) AR007648A1 (cs)
AT (1) ATE223707T1 (cs)
AU (1) AU2620197A (cs)
BR (1) BR9703771A (cs)
CO (1) CO4900025A1 (cs)
CZ (1) CZ205697A3 (cs)
DE (1) DE69715319T2 (cs)
DK (1) DK0815855T3 (cs)
ES (1) ES2183089T3 (cs)
HU (1) HUP9701113A2 (cs)
ID (1) ID17794A (cs)
IL (1) IL121145A0 (cs)
NO (1) NO972963L (cs)
NZ (1) NZ328182A (cs)
PL (1) PL320815A1 (cs)
PT (1) PT815855E (cs)
SG (1) SG54525A1 (cs)
TN (1) TNSN97111A1 (cs)
ZA (1) ZA975767B (cs)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9325445D0 (en) 1993-12-13 1994-02-16 Cortecs Ltd Pharmaceutical formulations
WO2000051570A1 (fr) * 1999-02-26 2000-09-08 Shionogi & Co., Ltd. Capsules molles a croquer presentant des proprietes d'administration ameliorees et leur procede de production
US20030060422A1 (en) 2001-08-31 2003-03-27 Balaji Venkataraman Tannate compositions and methods of treatment
US20050142204A1 (en) * 2001-09-18 2005-06-30 Loetter Antonie P. Triclosan dosage form
US8128957B1 (en) 2002-02-21 2012-03-06 Valeant International (Barbados) Srl Modified release compositions of at least one form of tramadol
US20050182056A9 (en) * 2002-02-21 2005-08-18 Seth Pawan Modified release formulations of at least one form of tramadol
US7670612B2 (en) 2002-04-10 2010-03-02 Innercap Technologies, Inc. Multi-phase, multi-compartment capsular delivery apparatus and methods for using same
EP1545468A4 (en) * 2002-09-20 2007-06-20 Alpharma Inc SUSTAINED RELEASE OPIOID PREPARATIONS AND METHODS OF USE
FR2850275B1 (fr) * 2003-01-24 2005-04-08 Scherer Technologies Inc R P Capsules molles a macher contenant une substance active a gout masque
US20040185032A1 (en) * 2003-03-18 2004-09-23 David Burrell Compositions and methods for treating colic
US7201920B2 (en) 2003-11-26 2007-04-10 Acura Pharmaceuticals, Inc. Methods and compositions for deterring abuse of opioid containing dosage forms
US20050249802A1 (en) * 2004-05-06 2005-11-10 The Procter & Gamble Company Softgel encapsulated pharmaceutical compositions comprising concentrated active ingredients
US20070036859A1 (en) * 2005-08-11 2007-02-15 Perry Ronald L Sustained release antihistamine and decongestant composition
WO2011041414A1 (en) * 2009-09-30 2011-04-07 Acura Pharmaceuticals, Inc. Methods and compositions for deterring abuse
JP2015512945A (ja) * 2012-04-13 2015-04-30 バナー ファーマキャップス，インコーポレイティド 錠剤と液体または半固体の充填剤とを含む軟質弾性カプセル、ならびにそれらの製造方法
WO2014085599A1 (en) 2012-11-30 2014-06-05 Acura Pharmaceuticals, Inc. Self-regulated release of active pharmaceutical ingredient
US9795569B2 (en) 2013-03-15 2017-10-24 Allergan Pharmaceuticals International Limited Pharmaceutical soft gelatin capsule dosage form with modified guar gum
AU2014306759B2 (en) 2013-08-12 2018-04-26 Pharmaceutical Manufacturing Research Services, Inc. Extruded immediate release abuse deterrent pill
US9492444B2 (en) 2013-12-17 2016-11-15 Pharmaceutical Manufacturing Research Services, Inc. Extruded extended release abuse deterrent pill
US10172797B2 (en) 2013-12-17 2019-01-08 Pharmaceutical Manufacturing Research Services, Inc. Extruded extended release abuse deterrent pill
US9642811B2 (en) 2014-03-26 2017-05-09 Sun Pharma Advanced Research Company Ltd. Abuse deterrent immediate release biphasic matrix solid dosage form
EP3169315B1 (en) 2014-07-17 2020-06-24 Pharmaceutical Manufacturing Research Services, Inc. Immediate release abuse deterrent liquid fill dosage form
US20160106737A1 (en) 2014-10-20 2016-04-21 Pharmaceutical Manufacturing Research Services, Inc. Extended Release Abuse Deterrent Liquid Fill Dosage Form
US11103581B2 (en) 2015-08-31 2021-08-31 Acura Pharmaceuticals, Inc. Methods and compositions for self-regulated release of active pharmaceutical ingredient
EP3758686B1 (en) * 2018-02-26 2024-11-06 R.P. Scherer Technologies, LLC Pharmaceutical dosage form for an emulsion of simethicone and loperamide
WO2020047205A1 (en) * 2018-08-31 2020-03-05 Arctic Therapeutics, Llc Novel topical formulation for intradermal application and uses thereof

Family Cites Families (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS59131355A (ja) * 1983-01-17 1984-07-28 森下仁丹株式会社 多重軟カプセルの製法
US4486412A (en) * 1983-03-15 1984-12-04 Pharmacaps, Inc. Encapsulated antacid dispersions
WO1986004501A1 (fr) * 1985-01-31 1986-08-14 Fujisawa Pharmaceutical Co., Ltd. Capsule souple a cavites multiples; son procede et appareil de fabrication
JPS61189230A (ja) * 1985-02-19 1986-08-22 Nippon Kayaku Co Ltd エトポシド製剤
GB8507779D0 (en) * 1985-03-26 1985-05-01 Fujisawa Pharmaceutical Co Drug carrier
US4639846A (en) * 1985-08-16 1987-01-27 Bbc Brown, Boveri & Company, Limited Method and compensating device for compensating current oscillations
US5209978A (en) * 1985-12-26 1993-05-11 Taisho Pharmaceutical Co., Ltd. Seamless soft capsule and production thereof
DE3600084A1 (de) * 1986-01-03 1987-07-09 Scherer Gmbh R P Formkoerper sowie verfahren und vorrichtung zur herstellung eines solchen formkoerpers
US4708834A (en) * 1986-05-01 1987-11-24 Pharmacaps, Inc. Preparation of gelatin-encapsulated controlled release composition
US5071643A (en) * 1986-10-17 1991-12-10 R. P. Scherer Corporation Solvent system enhancing the solubility of pharmaceuticals for encapsulation
DE3727894A1 (de) * 1987-08-21 1989-03-02 Stephan Dieter Kapsel fuer pharmazeutisch wirksame inhaltsstoffe einer droge
FR2624012B1 (fr) * 1987-12-07 1991-05-31 Fdb Ste Civile Rech Nouvelles compositions pharmaceutiques a action hypnotique a base d'hydrate de chloral
US4956184A (en) * 1988-05-06 1990-09-11 Alcide Corporation Topical treatment of genital herpes lesions
US4935243A (en) * 1988-12-19 1990-06-19 Pharmacaps, Inc. Chewable, edible soft gelatin capsule
US5073384A (en) * 1989-10-19 1991-12-17 Valentine Enterprises, Inc. Maltodextrin/defoaming composition combinate
GB8926612D0 (en) * 1989-11-24 1990-01-17 Erba Farmitalia Pharmaceutical compositions
IE64128B1 (en) * 1990-02-26 1995-07-12 Byrne Rynne Holdings Ltd A pharmaceutical composition
GB9022788D0 (en) * 1990-10-19 1990-12-05 Cortecs Ltd Pharmaceutical formulations
GR1002332B (el) * 1992-05-21 1996-05-16 Mcneil-Ppc Inc. Νεες φαρμακευτικες συνθεσεις που περιεχουν σιμεθεικονη.
US5501857A (en) * 1992-07-24 1996-03-26 Midwestern Bio-Ag Products & Services, Inc. Oral nutritional and dietary composition
ES2161768T3 (es) * 1993-06-30 2001-12-16 Fujisawa Pharmaceutical Co Medicamento encapsulado.
US5725846A (en) * 1995-03-02 1998-03-10 The Gillette Company Clear antiperspirant stick containing dibenzylidene alditol and hydroxyalkyl cellulose

Also Published As

Publication number Publication date
ES2183089T3 (es) 2003-03-16
TNSN97111A1 (fr) 2005-03-15
PL320815A1 (en) 1998-01-05
DE69715319D1 (de) 2002-10-17
MX9704846A (es) 1998-07-31
CN1172642A (zh) 1998-02-11
PT815855E (pt) 2003-01-31
NO972963D0 (no) 1997-06-25
ATE223707T1 (de) 2002-09-15
US6024980A (en) 2000-02-15
ZA975767B (en) 1998-12-28
DK0815855T3 (da) 2003-01-06
HU9701113D0 (en) 1997-08-28
CZ205697A3 (cs) 1998-01-14
NZ328182A (en) 1998-11-25
EP0815855B1 (en) 2002-09-11
SG54525A1 (en) 1998-11-16
NO972963L (no) 1997-12-29
IL121145A0 (en) 1997-11-20
KR980000438A (ko) 1998-03-30
JPH10182437A (ja) 1998-07-07
EP0815855A1 (en) 1998-01-07
CO4900025A1 (es) 2000-03-27
DE69715319T2 (de) 2003-01-23
AU2620197A (en) 1998-01-15
BR9703771A (pt) 1998-09-01
AR007648A1 (es) 1999-11-10
HUP9701113A2 (hu) 1998-08-28

Similar Documents

Publication Publication Date Title
NO994757D0 (no) FramgangsmÕte for oral administrasjon av proteiner
FI960584L (fi) Terapeuttisia peptidijohdannaisia
NO973938L (no) Farmasöytisk preparat av piperidinoalkanolforbindelser
NO990059D0 (no) Analoger av kationiske proteiner
NO973612D0 (no) Nytt farmasöytisk preparat
ATE223707T1 (de) Mehrphasige weichgelatine darreichungsform
FI953515L (fi) Fluoksetiinin farmaseuttiset formulaatiot
NO995134D0 (no) Forbedrede fremgangsmåter for fremstilling av aktivert protein C
DE69408321D1 (de) Zusammensetzung fuer weichgelatine kapsehuelle
FI932282L (fi) Protein c-derivat
NO943888D0 (no) Farmasöytisk preparat
BR9407178A (pt) Cápsula de gelatina
ATE264677T1 (de) Feste arzneizubereitung enthaltend benzofuranderivate
FI970113L (fi) Helico-bakteerin vastaisia atsolonien sulfonamidijohdannaisia
KR970000228A (ko) S-에토돌락의 경구용 제제
NO995251D0 (no) FremgangsmÕte for administrering av haloterapi
DE69812708D1 (de) Neue arzneimittel enthaltend uridintriphosphat
BR9610214A (pt) Compostos farmacéuticos
KR960016892A (ko) 약제의 신독성 경감제
ID23187A (id) Bentuk bentuk dosis sertralina lepas tunda
NO973610D0 (no) Nytt farmasöytisk preparat
DK0925273T3 (da) Farmaceutiske præparater indeholdende 4-oxo-butansyrer
DK1041966T3 (da) Farmaceutiske præparater omfattende zafirlukast
ID24673A (id) Bentuk-bentuk penakaran larutan sertralina dalam kapsul gelatin
FI964335A0 (fi) Kotelo